The Regenerative Medicine Industry is estimated to be valued at US$ 13.4 billion in 2023 and is expected to reach US$ 73.1 billion by 2033, developing at a CAGR of 18.5%, according to a new report by Future Market Insights (FMI). Regenerative medicine is a rapidly growing field of medicine that uses stem cells and …
Category Archives: Healthcare Trends
Neurotrophic Keratitis Treatment Market Aims for US$ 10 Billion Valuation by 2033 | Future Market Insights,Inc.
The global neurotrophic keratitis treatment market is on a trajectory of impressive growth, with a projected valuation of US$ 5 billion in 2023. According to a recent report by Future Market Insights, the market is expected to maintain a robust Compound Annual Growth Rate (CAGR) of 7.17% until 2033, eventually reaching a value of US$ …
Stretch Marks Treatment Market Reveals Skin’s Potential, Targeting US$ 5.82 Billion by 2033 | Future Market Insights,Inc.
During the forecast period, the Stretch Marks Treatment Market is expected to grow at a steady CAGR of 8.81%. The market is expected to generate US$ 2.5 billion in revenue in 2023, with a value of US$ 5.82 billion by 2033. More people turning obese, therefore, advanced treatment options and higher per capita income are pushing people …
Vutrisiran Market Soars: Projected to Exceed US$ 2 Billion by 2033 with a 12% CAGR| Future Market Insights,Inc.
Future Market Insights projects that the vutrisiran market will expand at a compound annual growth rate (CAGR) of 12% from 2023 to 2033. It is anticipated that the global market for Vutrisiran would reach a valuation of US$ 2087 million by 2033. Vutrisiran provides patients with hereditary transthyretin-mediated amyloidosis (hATTR) with hope and a new …
Skull Clamp Market Strengthening Cranial Care with a US$ 5.07 Billion Valuation by 2033
The Skull Clamp Market is expected to be valued at US$ 2.14 billion in 2023, rising to US$ 5.07 billion by 2033. During the forecast period, the market will grow at a CAGR of 9%. How Healthcare Manufacturers Are Growing the Global Market? Healthcare manufacturers are constantly looking for ways to improve and grow the market by developing new …
Autoimmune Disease Testing Market Set to Reach US$15.75 Billion by 2033| Future Market Insights,Inc.
The global market for Autoimmune Disease Testing is expected to grow from US$ 6.07 billion in 2023 to $15.75 billion by 2033. According to FMI, global demand for autoimmune disease testing could grow at a 10% CAGR from 2023 to 2033. The rising incidence of autoimmune disorders, such as rheumatoid arthritis, lupus, and multiple sclerosis, is fueling …
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Targeting US$ 185 Million by 2033| Future Market Insights,Inc.
The market for ESR1 Mutated Metastatic Breast Cancer Diagnostics was valued at US$ 58.70 million in 2022 and is projected to grow at a CAGR of 11% to reach US$ 185 million from 2023 to 2033. The market for ESR1 mutated metastatic breast cancer diagnostics is expanding as a result of rising breast cancer incidence and the …
Small-Scale Bioreactors Market Aims for US$7.71 Billion by 2033| Future Market Insights,Inc.
The Small-scale Bioreactors Market By 2033, the market is expected to be worth US$ 7.71 billion. The market is expected to grow at a CAGR of 14.8% over the forecast period. FMI estimates the market to be worth US$ 1.94 billion in 2023. New therapies are expected to be increasingly developed in the coming years due to …
Vascular Dementia Treatment Market Envisioned to Reach US$ 8.99 Billion by 2033| Future Market Insights,Inc.
The estimated growth for the vascular dementia treatment market, according to a recent research by Future Market Insights, suggests an increase in market value to US$ 5.64 billion in FY 2023, showing a year-over-year rise of over 5%. Furthermore, over the projection period from 2023 to 2033, the market is anticipated to expand at a …
Clinical Next-Generation Sequencing (NGS) Data Analysis Market is poised for growth, with an expected valuation of US$ 13.1 billion by 2033, as reported by FMI
As per Future Market Insights’ latest industry analysis, the valuation for the global Clinical Next-Generation Sequencing (NGS) Data Analysis Market was around US$ 2.3 Billion in 2022, and the market is projected to exhibit growth at a CAGR of 17.4% over the forecast period, with an estimated valuation of around US$ 13.1 Billion by 2033. …